AstraZeneca lifts 2024 outlook
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...
AstraZeneca now expects 2024 revenue and core earnings per share to grow by a high-teens percentage, from a previous forecast ...
The pharmaceutical giant expects overall sales and core earnings per share to rise by a high-teens percentage at constant ...
British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday a $3.5 billion capital investment in the United States, aiming to ...
AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...
Astrazeneca has raised its guidance for the full year despite issues surrounding its presence in China according to today's ...
The boss of AstraZeneca has said the group takes the probe in China that saw the detention of its president in the country ...
CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported third-quarter earnings of $1.43 billion. On a per-share basis, the Cambridge, Britain-based company said ...
AstraZeneca’s results were helped by resilient demand for its cancer and rare diseases medicines, after third-quarter ...
AstraZeneca is scheduled to report results for the third quarter on Tuesday. Here is what to know. CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback